MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 233 filers reported holding MYRIAD GENETICS INC in Q4 2015. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $20,742,000 | -77.2% | 1,244,300 | -71.9% | 0.01% | -76.7% |
Q3 2016 | $91,033,000 | -60.2% | 4,423,358 | -40.9% | 0.03% | -61.5% |
Q2 2016 | $228,953,000 | -29.0% | 7,482,135 | -13.2% | 0.08% | -29.7% |
Q1 2016 | $322,678,000 | -15.7% | 8,620,839 | -2.8% | 0.11% | -15.3% |
Q4 2015 | $382,960,000 | +14.3% | 8,873,032 | -0.8% | 0.13% | +9.2% |
Q3 2015 | $335,098,000 | +10.3% | 8,940,702 | 0.0% | 0.12% | +20.0% |
Q2 2015 | $303,894,000 | -4.0% | 8,940,702 | 0.0% | 0.10% | -7.4% |
Q1 2015 | $316,501,000 | +3.9% | 8,940,702 | 0.0% | 0.11% | +4.9% |
Q4 2014 | $304,520,000 | -11.6% | 8,940,702 | +0.1% | 0.10% | -13.4% |
Q3 2014 | $344,563,000 | +1.6% | 8,933,434 | +2.5% | 0.12% | 0.0% |
Q2 2014 | $339,289,000 | +17.7% | 8,717,609 | +3.4% | 0.12% | +14.4% |
Q1 2014 | $288,200,000 | +80.2% | 8,429,358 | +10.6% | 0.10% | +76.3% |
Q4 2013 | $159,970,000 | +18.7% | 7,624,885 | +32.9% | 0.06% | +11.3% |
Q3 2013 | $134,813,000 | +85.8% | 5,736,700 | +112.4% | 0.05% | +71.0% |
Q2 2013 | $72,573,000 | – | 2,700,900 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |